Net cashflow last quarter was negative 62m RMB , Nasdaq listing must be for raising cash come mid next year when they list. Seems unlikely they will keep an ASX listing as well.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
OAR Chris Judd's Talk Ya Book: Orthocell building on 'enormous potential' with steady growth - and US push to come